-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Cutting Through Bureaucratic Red Tape in Clinical Trials

Program: Spotlight Sessions
Session: Overcoming Obstacles to Activating and Accruing in Clinical Trials on Hematological Malignancies
Sunday, December 6, 2015, 4:30 PM-6:00 PM
W312, Level 3 (Orange County Convention Center)

Ann T Farrell, MD

Center for Drug Evaluation and Research, FDA, Silver Spring, MD

Disclosures: No relevant conflicts of interest to declare.

See more of: Overcoming Obstacles to Activating and Accruing in Clinical Trials on Hematological Malignancies
See more of: Spotlight Sessions
<< Previous Presentation | Next Presentation